In recent years, the company manufactured raw material for production of coenzyme Q10, and apheresis devices, where blood of a donor or patient is passed through an apparatus that separates out one particular constituent and returns the remainder to the circulation.

In 1950, the Osaka "Kanevinyl" plant was completed and the mass production of PVC wire covering started in Sakamoto factory.

Year later, the company developed vinyl chloride resin type "Kanebirakku" and started production in Osaka factory.

In 1993, the company established Nantong Sunrise Worsted Spinning Co., Ltd. as a joint venture with Kyusyu Kanekalon Co., Ltd. Kanematsu Corporation, and Toyobo Co., Ltd.

In 2010, the company developed new thermally conductive plastics with electric insulating properties, and the first dual UV/moisture-curing adhesive, together with ChemTech.

In 2011, the company developed the first completely bio-based polymer with soft and heat-resistant properties, as well as a new thermosetting imide resin for a carbon-fiber-reinforced composite material with high heat resistance.

In 2012, the company established Kaneka Asia Co., Ltd., an Asia regional umbrella hub based in Shanghai, China, as well as the Kaneka Americas Holding, Inc., an America regional umbrella hub based in Texas, United States.

In the same year the company founded Kaneka US Material Research Center Facility, in partnership with Texas A&M University.

[8] On March 6, 2015, the United States Food and Drug Administration authorized use of Lixelle Beta 2-microglobulin Apheresis Column, the first device to treat Haemodialysis-associated amyloidosis (DRA) developed and produced by Kaneka Corporation.